comparemela.com

Latest Breaking News On - Xeris careconnection - Page 1 : comparemela.com

Xeris Biopharma Holdings, Inc (NASDAQ:XERS) Q1 2024 Earnings Call Transcript

Xeris Biopharma Holdings, Inc (NASDAQ:XERS) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesXeris careconnectionOren livnatKelly closeAllison weyGvoke hypopenLeland gershellXerisol levothyroxineJohn shannonSteven pieperPaul edickDavid amsellemRoanna ruizRohan mathurSteve pieperPiper sandler

Xeris Biopharma Holdings Inc sees FDA grant Orphan-drug exclusivity to Recorlev for treatment of Cushing s syndrome

Xeris Biopharma Holdings (NASDAQ:XERS) Inc revealed that the Food and Drug Administration (FDA) granted its subsidiary Xeris Pharmaceuticals Inc,.

United statesXeris careconnectionPaulr edickXeris pharmaceuticals incDrug administrationXeris biopharma holdings

Xeris Biopharma Holdings, Inc (XERS) CEO Paul Edick on Q1 2022 Results - Earnings Call Transcript

Xeris Biopharma Holdings, Inc. (NASDAQ:NASDAQ:XERS) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Allison Wey - SVP, IR & Corporate Communications Paul.

United kingdomOren livnatXeris biopharmaXeris careconnectionPiper sandlerPaul edickAllison weyDavid amsellemSteve pieperRoanna ruizSilicon valley bankCompany participantsCorporate communicationsIr corporate communicationsXeris biopharma holdings incXeris biopharma holdings

Xeris Biopharma Reports First Quarter Financial Results and Upcoming Events

CHICAGO (BUSINESS WIRE) May 11, 2022

United statesSan diegoUnited kingdomAllison weyXeris biopharmaStrongbridge biopharmaXeris careconnectionPaulr edickSilicon valley bankArmistice capital master fund ltdXeris biopharma holdings incCorporate communicationsHayfin capital managementOxford financeXeris biopharma holdingsBiopharma holdings

Recorlev Now Available for Endogenous Hypercortisolemia in Cushing Syndrome

Recorlev (levoketoconazole) is now available for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome.

Xeris biopharmaXeris careconnectionKen johnsonPaulr edickGlobal developmentAffairs at xerisMedical affairsBoxed warningAccessed january

vimarsana © 2020. All Rights Reserved.